evaluate the pharmaceuticals company wegovy on glp-1 efficacy / effectiveness Comparing Ozempic, and Other Drugs Professor Receives Grant to Study

Todd Sohn, Strategas ETF & Technical Strategist, also joins the conversation.

The wild card-to-uncertainty about GLP-1 meds growth will be reimbursement: spending will continue to accelerate with upside if more widely reimbursed, IQVIA projects

Continuous personalized GLP-1 therapy addresses this biological reality

WHAT YOU CAN EXPECT: With consistent daily use many users notice early improvements in gut health, bowel regularity, and overall digestion within the first 10 days

It is equally about industrial policy, regulatory cooperation and long-term pharmaceutical resilience."At the regional level, the African Continental Free Trade Area (AfCFTA) provides an opportunity to strengthen regulatory cooperation and coordinate procurement strategies, ultimately increasing Africa's collective bargaining power."The COVID-19 lesson that risks being forgottenThe COVID-19 pandemic was widely expected to reshape the relationship between intellectual property and public health.In October 2020, South Africa and India proposed a temporary waiver of certain TRIPS obligations covering vaccines, diagnostics and treatments, arguing that existing intellectual property rules could become a barrier to equitable access during a global health emergency.The negotiations that followed demonstrated just how difficult it remains to reconcile commercial interests with public health priorities

Both Midi Health and Ro offer telehealth access to GLP-1 medications, but they differ significantly in clinical oversight, pricing models, and treatment personalization